8-(4-CHLOROPHENYL)-8-(2-METHYLROPOXY)-5-METHYL-8H-[1,4]-THIAZINO-[3,4-C]-[1,2,4]-OXADIAZOL-3-ONE
Compound with spectra: 1 NMR
![8-(4-CHLOROPHENYL)-8-(2-METHYLROPOXY)-5-METHYL-8H-[1,4]-THIAZINO-[3,4-C]-[1,2,4]-OXADIAZOL-3-ONE](/api/compound/F32wtsiOVz.png?ph=true&h=300&w=458 "8-(4-CHLOROPHENYL)-8-(2-METHYLROPOXY)-5-METHYL-8H-[1,4]-THIAZINO-[3,4-C]-[1,2,4]-OXADIAZOL-3-ONE")
| SpectraBase Compound ID | F32wtsiOVz |
|---|---|
| InChI | InChI=1S/C16H17ClN2O3S/c1-10(2)8-21-16(12-4-6-13(17)7-5-12)14-18-22-15(20)19(14)11(3)9-23-16/h4-7,9-10H,8H2,1-3H3 |
| InChIKey | NUKJMDCJFLMBDA-UHFFFAOYSA-N |
| Mol Weight | 352.84 g/mol |
| Molecular Formula | C16H17ClN2O3S |
| Exact Mass | 352.064841 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
8-(4-Fluorophenyl)-8-ethoxy-8H-[1,4]thiazino[3,4-c][1,2,4]oxadiazol-3-one
8-(4-Bromophenyl)-8-[(2Z)-hex-2-en-1-yloxy]-5-methyl-8H-[1,2,4]oxadiazolo[3,4-c][1,4]thiazin-3-one
1-[2-DEOXY-5-O-(4,4'-DIMETHOXYTRIPHENYLMETHYL)-BETA-D-THREO-PENTOFURANOSYL]-4-(2-METHYLPROPANOYL)-CYTOSINE
(3-benzoyl-1,5-diphenyl-4-pyrazolyl)-phenylmethanone
2-(4-Methoxyphenyl)-5,10-dihydro-4H-5,10-epoxybenzo[5,6]cyclohepta[1,2-b]furan
EGC-3'-GLUC;(-)-EPIGALLOCATECHIN-3'-GLUCURONATE
3-Methyl-2-phenyl-2H-pyrazino[2,1-b]quinazoline-1,6-dione
1-(4-hydroxyphenyl)-7,7-dimethyl-4-(4-nitrophenyl)-3,4,6,8-tetrahydroquinoline-2,5-dione
3,8,9-Trichloro-1-(3-chloropropyl)-1,10-phenanthrolin-2(1H)-one
cis-1-Chloro-1,2,2,3,3,4,4,5,5,6,6-decaisopropylcyclohexasilane
| Title | Journal or Book | Year |
|---|---|---|
| Cardiovascular Characterization of [1,4]Thiazino[3,4-c][1,2,4]oxadiazol-1-one Derivatives: Selective Myocardial Calcium Channel Modulators | Journal of Medicinal Chemistry | 2002 |